“…Besides the EGFR, the ubiquitination, endosomal lysosomal trafficking, and/or stability of many other transmembrane proteins have been shown to be regulated by USP8. These include the hepatocyte growth factor receptor MET [19], ERBB2 [35], the G protein-coupled receptor protease-activated receptor 2 [36]; chemokine receptor 4 [37], the Wg/Wnt receptor Frizzled [38],the calcium-activated potassium channel KCa3.1 [39], the epithelial Na+ channel ENaC [40], the low-density lipoprotein receptor (LDLR) [41,42], leucine-rich repeats and Ig-like domains 1 (LRIG1, a negative regulator of RTKs) [22,23], AMPA receptors [43], Tropomyosin related kinase A (TrkA) [44], vascular endothelial growth factor receptor 2 (VEGFR2) [45], β-site amyloid precursor protein-cleaving enzyme (BACE1) [46], connexin-43 [47], and leptin receptor [48]. Despite suggesting a common mode of action, conclusions on the impact of USP8 on protein stability in these studies are highly diverse and the precise molecular mechanisms remain elusive.…”